About Arix Bioscience
Arix Bioscience is a company based in London (United Kingdom) founded in 2016 was acquired by RTW Investments in November 2023. The company has 331 employees as of December 31, 2021.
- Headquarter London, United Kingdom
- Employees 331 as on 31 Dec, 2021
- Stage Public
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$138.53 K (USD)-67as on Dec 31, 2022
-
Net Profit
-$34.11 M (USD)55as on Dec 31, 2022
-
EBITDA
-$34.11 M (USD)55as on Dec 31, 2022
-
Latest Funding Round
$4.92 M (USD), Post-IPO
Mar 20, 2018
- Investors
-
Employee Count
331
as on Dec 31, 2021
-
Acquired by
RTW Investments
(Nov 01, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Arix Bioscience
Unlock access to complete
Unlock access to complete
Funding Insights of Arix Bioscience
Investors in Arix Bioscience
Arix Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include RTW Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Arix Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arix Bioscience
Investment portfolio details for Arix Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Arix Bioscience
Detailed financials for Arix Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arix Bioscience Comparisons
Peer comparison for Arix Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arix Bioscience
Detailed competitors of Arix Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arix Bioscience
Complete news archive for Arix Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arix Bioscience
Arix Bioscience was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Arix Bioscience is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Robert Lyne is the current CEO of Arix Bioscience.
As of Dec 31, 2021, the latest employee count at Arix Bioscience is 331.
Annual revenue of Arix Bioscience is $138.53K as on Dec 31, 2022.
Arix Bioscience was founded in 2016 as a venture capital fund based in London, United Kingdom. Focus is placed on the life sciences sector, where investments are directed toward biotech companies. Operations involve funding and developing startups in biotechnology. Support is provided for building innovative firms within this domain, with activities centered on early-stage opportunities in the industry.
Arix Bioscience has 1 investor. Key investors include RTW Investments.